Multiplexed shRNA-miRs as a candidate for anti HIV-1 therapy: strategies, challenges, and future potential.

Jai J, Shirleen D, Hanbali C, Wijaya P, Anginan TB, Husada W, Pratama MY.

Open source

DOI
10.1186/s43141-022-00451-z
Published
2022-12-28
Container
J Genet Eng Biotechnol
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s43141-022-00451-z,
  title = {Multiplexed shRNA-miRs as a candidate for anti HIV-1 therapy: strategies, challenges, and future potential.},
  author = {Jai J and  Shirleen D and  Hanbali C and  Wijaya P and  Anginan TB and  Husada W and  Pratama MY.},
  year = {2022},
  journal = {J Genet Eng Biotechnol},
  doi = {10.1186/s43141-022-00451-z},
  url = {https://doi.org/10.1186/s43141-022-00451-z}
}

RIS

TY  - JOUR
TI  - Multiplexed shRNA-miRs as a candidate for anti HIV-1 therapy: strategies, challenges, and future potential.
AU  - Jai J
AU  -  Shirleen D
AU  -  Hanbali C
AU  -  Wijaya P
AU  -  Anginan TB
AU  -  Husada W
AU  -  Pratama MY.
PY  - 2022
JO  - J Genet Eng Biotechnol
DO  - 10.1186/s43141-022-00451-z
UR  - https://doi.org/10.1186/s43141-022-00451-z
ER  - 

APA

J, J., D, S., C, H., P, W., TB, A., W, H., & MY., P. (2022). Multiplexed shRNA-miRs as a candidate for anti HIV-1 therapy: strategies, challenges, and future potential.. J Genet Eng Biotechnol. https://doi.org/10.1186/s43141-022-00451-z

Source records